ESR1 and breast cancer: Our model, based on our results and those of others, provides two potential escape routes in ER-dependent breast cancer senescent cells: excess nuclear cyclin D1 binds to (1) ERα and/or (2) p53 and potentiates proliferation (Figure 9).